Join this four-chapter webinar hosted by the Gateway Hemophilia Association (via Zoom), presented and sponsored by CSL Behring.
This educational program will offer you and your family the opportunity to:
- learn about HEMGENIX, the first and only gene therapy approved for Hemophilia B.
- gain insightful information and deepen your understanding of HEMGENIX through a live Q & A session
Date(s) - May 17 2023 at 7:00 PM - 9:00 PM